Takeda Pharmaceutical Co Ltd - Significant Ownership

Signature - Title
/s/ Paul Sundberg - Paul Sundberg / Authorized Signatory
Location
Tokyo, Japan
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Takeda Pharmaceutical Co Ltd.

Significant Ownership of Takeda Pharmaceutical Co Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HLVX HILLEVAX, INC. Common Stock, par value $0.0001 per share 0% $0 0 Takeda Pharmaceutical Company Limited Sep 17, 2025

Schedules 13D/G Reported by Takeda Pharmaceutical Co Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.